Sign In
Buy OGN
$13.40
+0.0200 (+0.149%)
At Close: Jun 03, 2026
Organon To Present at Morgan Stanley's 19th Annual Global Healthcare Virtual Conference
08:15am, Wednesday, 01'st Sep 2021
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in
Organon To Present at Citi's 16th Annual BioPharma Virtual Conference
08:00am, Wednesday, 01'st Sep 2021
JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Health--Organon (NYSE: OGN), announced today that Kevin Ali, Chief Executive Officer, and Matthew Walsh, Chief Financial Officer, are scheduled to participate in
Avestria Ventures Closes Fund I
09:30am, Thursday, 26'th Aug 2021
SAN FRANCISCO--(BUSINESS WIRE)-- #femalefounders--Avestria Ventures closes Fund I. The Bay Area-based venture capital firm invests in women's health and female-led life science ventures.
Jeff Auxier Discloses Position in Organon, Curbs Several Top Holdings
05:00pm, Monday, 23'rd Aug 2021
Auxier Asset Management leader Jeff Auxier (Trades, Portfolio) released his second-quarter portfolio last week.
4 Incredible Blue-Chip Bargains You Won't Want To Miss
04:10am, Thursday, 19'th Aug 2021
4 Incredible Blue-Chip Bargains You Won't Want To Miss
Top Stocks Warren Buffett Just Bought
05:30pm, Wednesday, 18'th Aug 2021
These were Berkshire Hathaway's biggest buys during Q2, 2021.
GuruFocus Announces Winner of 2nd-Quarter Warren Buffett Contest
05:39pm, Tuesday, 17'th Aug 2021
GuruFocus is proud to announce that there was one winner of the second-quarter Warren Buffett (Trades, Portfolio) contest: Steak.
11 Stocks Warren Buffett Is Selling (And 3 He's Buying)
07:23pm, Monday, 16'th Aug 2021
Berkshire Hathaway CEO Warren Buffett and his team were bears yet again in Q2 2021, hacking away at a large number of positions while only adding to a handful.
Organon: Q2 Earnings Should Alleviate Bear Concerns
02:37am, Saturday, 14'th Aug 2021
Organon: Q2 Earnings Should Alleviate Bear Concerns
Organon Stock Jumps On Profit Beat In First Post-Spinoff Report
12:18pm, Friday, 13'th Aug 2021
Total revenue of $1.6 billion grew by a modest 4.5% YOY (-1% excluding foreign currency impact or excl.fx) reflecting the impact of loss of exclusivity on some products, but beat consensus by 5.2%.
Value Stock Selections: A Simpler Benjamin Graham
10:26am, Friday, 13'th Aug 2021
Benjamin Graham is known for developing a fairly complex set of rules and formulas to determine a stock's intrinsic value. In his final year, Graham offered a much simpler means of finding value, but
Organon's (OGN) CEO Kevin Ali on Q2 2021 Results - Earnings Call Transcript
02:32pm, Thursday, 12'th Aug 2021
Organon's (OGN) CEO Kevin Ali on Q2 2021 Results - Earnings Call Transcript
Organon's (OGN) Q2 Earnings & Revenues Surpass Estimates
12:25pm, Thursday, 12'th Aug 2021
Organon's (OGN) earnings and revenues beat estimates in the second quarter of 2021. Stock up in pre-market trading.
Merck profit nearly halves on Organon spin off
06:37am, Thursday, 29'th Jul 2021
Merck & Co Inc on Thursday reported a 49% fall in second-quarter profit after it spun off its women's health and biosimilar assets into Organon in June.
5 Undervalued Stocks Popular Among Gurus
05:25pm, Tuesday, 27'th Jul 2021
GuruFocus' Most Broadly Held model portfolio consists of the 25 stocks that have the highest number of guru owners, rebalanced annually.
